This study aims to investigate the effects of obstructive sleep apnea (OSA) on executive function and empathy development in children aged 3-12 years. The study will compare the outcomes of different treatment approaches (surgical vs. pharmacological) in children with mild OSA and track the progression of cognitive and emotional functions over 12 months. The study will also explore potential EEG biomarkers for assessing neurological damage in OSA children.
Children aged 3-12 years.
Diagnosed with OSA due to adenoid and/or tonsillar hypertrophy.
IQ ≥ 85.
Parental consent for participation.
Other primary sleep disorders (e.g., narcolepsy, restless leg syndrome).
Developmental delay, epilepsy, or other neurological/metabolic disorders.
Chronic diseases or history of head trauma.